Cost Control to Capability Building: Rethinking Supply and Strategy in Pharma

In this episode of Denatured, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney will explore how healthcare and pharmaceutical players — from hospitals and universities to manufacturers and investors — are rethinking their strategies amid global supply chain disruption.The conversation highlights both immediate operational responses and long-term structural shifts shaping a more resilient, agile, and locally grounded ecosystem, especially in light of U.S. tariffs.This episode is presented in partnership with Element Materials Technology.HostsJennifer Smith-Parker, Director of Insights, BioSpaceLori Ellis, Head of Insights, BioSpaceGuestsDr. Jihye Jang-Lee, Director of Technical Services, Element Materials TechnologyDr. Khanh Courtney, Biologics Technical Strategy Manager, Element Materials TechnologyDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

There are no comments yet.

Please log in to write the first comment.